메뉴 건너뛰기
BMJ
Volumn 327, Issue 7416, 2003, Pages 681-682
Time of taking ramipril may account for lack of relation between blood pressure and outcome
Author keywords

[No Author keywords available]
Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PLACEBO; RAMIPRIL;
EID: 0141566244     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.327.7416.681-c     Document Type: Letter
Times cited : (8)
References (5)
  • 1
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • HOPE Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–53.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
  • 2
    • 0035936402 scopus 로고    scopus 로고
    • Blood pressure reduction and cardiovascular risk in HOPE study
    • Sleight P, Yusuf S, Pogue J, Psuyuki R, Probstfield J. Blood pressure reduction and cardiovascular risk in HOPE study. Lancet 2001; 358: 2130–1.
    • (2001) Lancet , vol.358 , pp. 2130-2131
    • Sleight, P.1    Yusuf, S.2    Pogue, J.3    Psuyuki, R.4    Probstfield, J.5
  • 3
    • 0037160928 scopus 로고    scopus 로고
    • Effect of ramipril in preventing stroke: double blind randomised trial
    • Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, et al. Effect of ramipril in preventing stroke: double blind randomised trial. BMJ 2002; 324: 699–702.
    • (2002) BMJ , vol.324 , pp. 699-702
    • Bosch, J.1    Yusuf, S.2    Pogue, J.3    Sleight, P.4    Lonn, E.5    Rangoonwala, B.6
  • 4
    • 17044440752 scopus 로고    scopus 로고
    • Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy
    • Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension 2001; 38: e28–e32.
    • (2001) Hypertension , vol.38 , pp. e28-e32
    • Svensson, P.1    de Faire, U.2    Sleight, P.3    Yusuf, S.4    Ostergren, J.5
  • 5
    • 48049115422 scopus 로고    scopus 로고
    • Blood pressure and cardiovascular risk in the HOPE study. Author's reply
    • Sleight P, Pogue J, Yusef S. Blood pressure and cardiovascular risk in the HOPE study. Author's reply. Lancet 2002; 359: 2118.
    • (2002) Lancet , vol.359 , pp. 2118
    • Sleight, P.1    Pogue, J.2    Yusef, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.